Cannabis compositions and methods of making the same

Information

  • Patent Grant
  • 12225913
  • Patent Number
    12,225,913
  • Date Filed
    Friday, June 23, 2023
    a year ago
  • Date Issued
    Tuesday, February 18, 2025
    2 months ago
Abstract
Disclosed herein are new cannabis compositions. In one embodiment, these new cannabis compositions are beverages, such as tea. In one embodiment, these new cannabis compositions are dehydrated beverages, such as powders or crystalline forms, which can be mixed with other components, like tea, and added to water.
Description
TECHNICAL FIELD

This disclosure relates to the cannabis industry. In particular, the disclosure relates to cannabis compositions for use in the making beverages, methods of making beverages, and beverages.


BACKGROUND

Cannabis has a long history of being consumed for many purposes and in many forms. The psychoactive effects of cannabis are well known, however the medical benefits are just as useful. Treating glaucoma, pain management, appetite stimulation and easing anxiety are just a few of the potential benefits. The source of these effects are in the cannabinoids, a class of compounds found exclusively in the cannabis plant. Currently there are 483 identified compounds found in cannabis. The most well known, and in some ways the most important, is tetrahydrocannabniol (THC). THC is responsible for many of the psychoactive effects as well as the medicinal effects. Cannabidiol (CBD) is also another major cannabinoid comprising up to 40% of cannabis extract and could have as many health benefits as THC.


Many methods exist for extracting the cannabinoids from the cannabis plant. A common method is alcohol extraction. Using a solvent to extract the cannabinoids and then evaporating the alcohol leaving a resin. Further extraction and evaporation can yield a product that is closer to a solid. Another common method for the purposes of making edibles is placing the cannabis leaves in butter, heavy cream, oil, etc. and then heating to extract the cannabinoids. The end product is then used as an ingredient in baking or cooking which usually results in a high caloric food due to the fat needed to extract the cannabinoids. Cannabinoids are soluble in fats and alcohols. Which is why when making cannabis tea the cannabinoids have to be already extracted. Just placing cannabis leaves in hot water will not effectively extract any of the vital cannabinoids.


However, the state of the art has many shortcomings. The cannabis arts do not have homogenous cannabis beverages. Existing cannabis beverages include large amounts of caloric material. Existing cannabis beverages are not capable of providing consistent cannabinoid concentrations, especially at low cannabinoid concentrations.


There exists a need for homogenous cannabis beverages. In particular there exists a need for beverages providing a consistent amount of the cannabinoid, especially at low doses.







DETAILED DESCRIPTION

Disclosed herein are new cannabis compositions. In one embodiment, these new cannabis compositions are beverages, such as tea. In one embodiment, these new cannabis compositions are dehydrated beverages, such as powders or crystalline forms, which can be mixed with other components, like tea, and added to water.


In one embodiment, the disclosed cannabis compositions are homogenous. In one embodiment, the disclosed cannabis compositions include a surfactant and a carrier oil. In one embodiment, the disclosed cannabis compositions are consistent with respect to cannabinoid amount. In one embodiment, the disclosed cannabis compositions are low-calorie cannabis beverages, such as low calorie cannabis teas.


Disclosed herein are new compositions comprising:

    • a cannabinoid,
    • a surfactant, and
    • a carrier oil.


As used herein the term “cannabinoid” refers to a compound that acts on the cannabinoid receptor. In one embodiment of this disclosure, the compositions are low dose compositions having 0.1 to 10 mg of cannabinoid. In some embodiments, the composition comprises between 0.5 to 5 mg.


In other embodiments of this disclosure, higher amounts of cannabinoid can be used, such as more than 10 mg, for example 20-500 mg or 50-200 mg.


Examples of cannabinoids are tetrahydrocannabinol, cannabidiol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, cannabielsoin, cannabicitran, cannabigerolic acid, cannabigerolic acid monomethylether, cannabigerol monomethylether, cannabigerovarinic acid, cannabigerovarin, cannabichromenic acid, cannabichromevarinic acid, cannabichromevarin, cannabidolic acid, cannabidiol monomethylether, cannabidiol-C4, cannabidivarinic acid, cannabidiorcol, delta-9-tetrahydrocannabinolic acid A, delta-9-tetrahydrocannabinolic acid B, delta-9-tetrahydrocannabinolic acid-C4, delta-9-tetrahydrocannabivarinic acid, delta-9-tetrahydrocannabivarin, delta-9-tetrahydrocannabiorcolic acid, delta-9-tetrahydrocannabiorcol, delta-7-cis-iso-tetrahydrocannabivarin, delta-8-tetrahydrocannabiniolic acid, delta-8-tetrahydrocannabinol, cannabicyclolic acid, cannabicylovarin, cannabielsoic acid A, cannabielsoic acid B, cannabinolic acid, cannabinol methylether, cannabinol-C4, cannabinol-C2, cannabiorcol, 10-ethoxy-9-hydroxy-delta-6a-tetrahydrocannabinol, 8,9-dihydroxy-delta-6a-tetrahydrocannabinol, cannabitriolvarin, ethoxy-cannabitriolvarin, dehydrocannabifuran, cannabifuran, cannabichromanon, cannabicitran, 10-oxo-delta-6a-tetrahydrocannabinol, delta-9-cis-tetrahydrocannabinol, 3, 4, 5, 6-tetrahydro-7-hydroxy-alpha-alpha-2-trimethyl-9-n-propyl-2, 6-methano-2H-1-benzoxocin-5-methanol-cannabiripsol, trihydroxy-delta-9-tetrahydrocannabinol, and cannabinol. Examples of cannabinoids within the context of this disclosure include tetrahydrocannabinol and cannabidiol.


As used herein, the term “tetrahydrocannabinol” (THC) refers to a compound having the following structural formula:




embedded image


As used herein, the term “cannabidiol” (CBD) refers to a compound having the following structural formula:




embedded image


As used herein the term “surfactant” refers to a compound that lowers the surface tension between two liquids or between a liquid and solid. Surfactants can be anionic, cationic, non-ionic and amphoteric. Examples of surfactants are ammonium lauryl sulfate, dioctyl sodium sulfosuccinate, perflurooctanoic acid, potassium lauryl sulfate, soap, sodium dodecyl sulfate, sodium dodecylbenzenesulfonate, sodium laureth sulfate, sodium lauroyl sarcosinate, sodium myreth sulfate, sodium pareth sulfate, sodium stearate, perflurobutanesulfonic acid, perfluorononanoic acid, perlurooactanesulfonic acid, benzalkonium chloride, benzethonium chloride, bronidox, dimethyldioctadecylammonium chloride, lauryl methyl gluceth-10 hydroxypropyl dimonium chloride, cetrimonium bromide, cetrimonium chloride, tetramethylammonium hydroxide, cetomacrogol 1000, cetostearyl alcohol, cetyl alcohol, cocamide DEA, cocamide MEA, NP-40, octaethylene glycol monododecyl ether, N-octyl beta-D-thoglucopyranoside, octyl glucoside, oleyl alcohol, decyl glucoside, pentaethylene glycol monododecyl ether, poloxamer 407, polyglycerol polyricinolate, polysorbate, polysorabte 20, IGEPAL CA-630, isoceteth-20, lauryl glucoside, lecithin, sodium lauroampoacetate, cocamidopropyl betaine, hydroxysultaine, stearyl alcohol, decyl glucoside, octaethylene glycol monododecyl ether, nonoxynol-9, monolaurin, oleyl alcohol, poloxamer, sorbitan monostearate, polysorbate 80 and glycerol monostearate. Examples of surfactants within the context of this disclosure include polysorbate 80 and/or glycerol monostearate.


As used herein, the term “polysorbate 80” refers to a compound having the following structure:




embedded image


As used herein the term “glycerol monostearate” refers to a compound having the following structure:




embedded image


As used herein the term “carrier oil” refers to an oil that can be used to form a homogenized mixture with cannabis oil. Examples include coconut oil, palm oil, palm kernel oil, hemp oil, caproic acid and caprylic acid. One example of carrier oils within the context of this disclosure is medium chain triglycerides. Another example of a carrier oil within the context of this disclosure is coconut oil. Another example of a carrier oil within the context of this disclosure is hemp oil.


As used herein the term coconut oil means oil extracted from the kernel or meat of coconuts. Coconut is the fruit of the coconut palm. Coconut oil is noted for it's high saturated content. Examples include lauric acid, myristic acid, palmitic acid, and decanoic acid.


As used herein the term hemp oil refers to oil obtained from hemp seeds. Hemp seeds come from a variety of the Cannabis sativa plant that does not contain a high amount of tetrahydrocannabinol. The oil is about 80% essential fatty acids. Examples include linolenic acid, omega-6, alpha-linolenic acid, and omega-3.


In one embodiment, the composition comprises a cannabinoid, a surfactant, a carrier oil, and a sugar alcohol.


As used herein the term “sugar alcohol” refers to alcohols prepared from sugars with the general chemical formula HOCH2(CHOH)nCH2OH. Examples include glycerol, erythritol, threitol, arabitol, xylitol, mannitol, ribitol, mannitol, galacitol, fucitol, inositol, volemitol, maltitol, lacitol, malootetraitol, polyglycitol, sorbitol, iditol, isomalt, and maltotriitol. Examples of sugar alcohols within the context of this disclosure include glycerol/glycerin or sorbitol.


As used herein, the term “glycerol” refers to a compound having the following structure:




embedded image


As used herein, the term “sorbitol” refers to a compound having the following structure:




embedded image


In one embodiment, the composition disclosed herein comprises a cannabinoid, a surfactant, a carrier oil, and a gelling agent.


As used herein, the term “gelling agent” means a substance that dissolves in the liquid phase and forms a weak cohesive internal structure. Examples include natural gums, starches, pectins, agar-agar, and gelatin.


As used herein, the term “gelatin” refers to a gelling agent derived from the collagen of various all byproducts.


In one embodiment, the composition comprises a cannabinoid, a surfactant, a carrier oil, and has less than 10 mass % water. In one embodiment, the composition is a solid. In one embodiment, the composition is a granual.


As used herein, the term “less than 10 mass % water” means less than 10% of water, by mass, of the composition.


In one embodiment, the composition comprises a cannabinoid, a surfactant, a carrier oil, and has more than 95 mass % water.


As used herein, the term “more than 95 mass % water” means less than 95% of water, by mass, of the composition.


In one embodiment, the composition comprises a cannabinoid, a surfactant, a carrier oil, and a flavoring agent.


As used herein, the term “flavoring agent” means a compound that adds a flavor to a composition. A few examples of flavoring agents include amyl acetate, benzaldehyde, ethyl butyrate, methyl anthranilate, methyl salicylate, fumaric acid, diacetyl, cinnamaldehyde, ethyl propionate, limonene, ethyl decadienoate, allyl hexanoate, ethyl maltol, ethylvanillin, and methyl salicylate.


In one embodiment, the composition comprises a coloring agent. As used herein, the term “coloring agent” means any substance that adds or changes the color of the substance to which the coloring agent is added. Within the context of this application, examples of the term coloring agent include any dye, pigment or substance that imparts color when it is added to food or drink. The coloring agent can be natural or non-natural. Such agents come in many forms, including liquids, powders, gels, dyes, lakes, and pastes. In one exemplary embodiment, one or more coloring agents can be added to the compositions of this disclosure to match the coloring between two ingredients. In one example, brownish color is added to a compositions comprising a cannabinoid, a surfactant, and a carrier oil in order to make the said compositions take on the color of natural tea.


In one embodiment, the composition comprises a cannabinoid, a surfactant, a carrier oil, and tea. In one embodiment the tea are tea leaves. As used herein, the term “tea” is meant to include any composition that is similar or labeled as tea, either natural or synthetic. Tea refers to both artificially flavored and/or artificially colored compositions in addition to all forms of natural tea leaves. In one embodiment, the cannabis compositions are brown granules.


As used herein the term “tea leaves” refers to forms of the plant Camellia sinensis.


In one embodiment, the composition comprises less than 4 grams of caloric mass. In one embodiment the caloric mass is less than 2 grams. As the herein the term “caloric mass” means mass metabolized by humans to generate energy. Examples include carbohydrates and proteins which give 4 cal/gram and fats which give 9 cal/gram.


In one embodiment, the composition comprises 0.5 to 5 mg of the cannabinoid is present in a consistent amount, having less than 0.2 mg of deviation across sample portions of the composition.


As used herein the term “consistent amount” means a collection of samples would all have relatively similar amounts of the cannabinoid. Similar means limited amount of deviation in the mass of the cannabinoid. For example, if a collection of compositions were analyzed to determine the mass of cannabinoid present, each sample in that collection would have a similar mass of cannabinoid present in relation to the total amount of each composition.


In one embodiment, the composition comprises:






    • cannabis oil having 1.5 to 3.5 mg of THC;

    • glycerine,

    • sorbitol,

    • gelatin,

    • glycerol monostearate,

    • polysorbate 80, and

    • coconut oil.


      In one embodiment, the composition comprises:

    • cannabis oil having 1.5 to 3.5 mg of THC;

    • glycerine,

    • sorbitol,

    • gelatin,

    • glycerol monostearate,

    • polysorbate 80,

    • coconut oil, and

    • tea.


      In one embodiment, the composition comprises:

    • cannabis oil having 1.5 to 3.5 mg of THC;

    • glycerine,

    • sorbitol,

    • gelatin,

    • glycerol monostearate,

    • polysorbate 80,

    • coconut oil,

    • and greater than 95 mass % of water.


      In one embodiment, the composition comprises:

    • cannabis oil having 1.5 to 3.5 mg of THC;

    • glycerine,

    • sorbitol,

    • gelatin,

    • glycerol monostearate,

    • polysorbate 80,

    • coconut oil,

    • and less than 5 mass % of water.





EXAMPLES

Although the present invention herein has been described with reference to various exemplary embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. Those having skill in the art would recognize that various modifications to the exemplary embodiments may be made, without departing from the scope of the invention.


Moreover, it should be understood that various features and/or characteristics of differing embodiments herein may be combined with one another. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the scope of the invention.


Furthermore, other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a scope and spirit being indicated by the claims.


Finally, it is noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the,” include plural referents unless expressly and unequivocally limited to one referent, and vice versa. As used herein, the term “include” or “comprising” and its grammatical variants are intended to be non-limiting, such that recitation of an item or items is not to the exclusion of other like items that can be substituted or added to the recited item(s).


The gram amounts of ingredients depend on the batch size. Gram amounts for batches can be determined by following the mixing guidelines below.
















Ingredient
Parts









Water
 8-12



Surfactant
  1-1.5



Carrier Oil
4



Cannabinoid
1



Sugar alcohol
30-70



Gelling agent
0.3-0.5










Example 1





    • 1) Surfactants were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Carrier oil and cannabis oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.

    • 3) A first sugar alcohol and gelling agent were added to water at 40 C. The mixture was heated to 80 C.

    • 4) A second sugar alcohol was added to the mixture of sugar alcohol and gelling agent over the course of 5 minutes and mixed until well blended.

    • 5) The sugar blend was added to the mixture of cannabis oil, carrier oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.

    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.

    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.

    • 8) The films were dried for 24 hours, to provide brittle, dry films.

    • 9) The dry films were broken into smaller pieces.

    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.

    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.





Example 2

1) Glycerol monostearate and polysorbate 80 were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Carrier and cannabis oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.
    • 3) Glycerin and gelatin were added to water at 40 C. The mixture was heated to 80 C.
    • 4) Sorbitol was added to the mixture of glycerin and gelatin over the course of 5 minutes and mixed until well blended.
    • 5) The blend of sorbitol, glycerine, and gelatin was added to the mixture of cannabis oil, coconut oil, glycerol monostearate, and polysorbate 80 over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.
    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.
    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.
    • 8) The films were dried for 24 hours, to provide brittle, dry films.
    • 9) The dry films were broken into smaller pieces.
    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.
    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.


Example 3





    • 1) Surfactants were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Carrier oil and CBD oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.

    • 3) A first sugar alcohol and gelling agent were added to water at 40 C. The mixture was heated to 80 C.

    • 4) A second sugar alcohol was added to the mixture of sugar alcohol and gelling agent over the course of 5 minutes and mixed until well blended.

    • 5) The sugar blend was added to the mixture of CBD oil, carrier oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.

    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.

    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.

    • 8) The films were dried for 24 hours, to provide brittle, dry films.

    • 9) The dry films were broken into smaller pieces.

    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.

    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.





Example 4





    • 1) Surfactants were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Coconut oil and cannabis oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.

    • 3) A first sugar alcohol and gelling agent were added to water at 40 C. The mixture was heated to 80 C.

    • 4) A second sugar alcohol was added to the mixture of sugar alcohol and gelling agent over the course of 5 minutes and mixed until well blended.

    • 5) The sugar blend was added to the mixture of cannabis oil, coconut oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.

    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.

    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.

    • 8) The films were dried for 24 hours, to provide brittle, dry films.

    • 9) The dry films were broken into smaller pieces.

    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.

    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.





Example 5





    • 1) Surfactants were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Hemp oil and cannabis oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.

    • 3) A first sugar alcohol and gelling agent were added to water at 40 C. The mixture was heated to 80 C.

    • 4) A second sugar alcohol was added to the mixture of sugar alcohol and gelling agent over the course of 5 minutes and mixed until well blended.

    • 5) The sugar blend was added to the mixture of cannabis oil, hemp oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.

    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.

    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.

    • 8) The films were dried for 24 hours, to provide brittle, dry films.

    • 9) The dry films were broken into smaller pieces.

    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.

    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.





Example 6





    • 1) Surfactants were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.

    • 2) Carrier oil and cannabis oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.

    • 3) A first sugar alcohol and gelatin were added to water at 40 C. The mixture was heated to 80 C.

    • 4) A second sugar alcohol was added to the mixture of sugar alcohol and gelatin over the course of 5 minutes and mixed until well blended.

    • 5) The sugar blend was added to the mixture of cannabis oil, carrier oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.

    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.

    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.

    • 8) The films were dried for 24 hours, to provide brittle, dry films.

    • 9) The dry films were broken into smaller pieces.

    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.

    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.





Example 7

To make 2300 tea sticks

    • 1) 67 grams of glycerol monostearate and 40 grams of polysorbate 80 were added to a beaker and heated to 80 C with a hot plate for 10 minutes to provide a homogeneous surfactant blend.
    • 2) 341 grams of coconut oil and 85 grams of THC oil were added to the surfactant blend and stirred for 10 minutes at 60 C, to provide a homogenous mixture.
    • 3) 213 grams of glycerin and 32 grams of gelatin were added to 852 grams of water at 40 C. The mixture was heated to 80 C.
    • 4) 4259 grams of sorbitol was added to the mixture of glycerin and gelatin over the course of 5 minutes and mixed until well blended.
    • 5) The sugar blend was added to the mixture of THC oil, coconut oil and surfactant blend over 10 minutes and the combined mixture was heated to 80 C to provide a homogenize mixture with no phase separation.
    • 6) The homogenized mixture was poured into trays, to create thin films, which were refrigerated for 60 minutes.
    • 7) After cooling for 60 minutes, the films were place in a dehydrator at 40 C.
    • 8) The films were dried for 24 hours, to provide brittle, dry films.
    • 9) The dry films were broken into smaller pieces.
    • 10) 10 gram portions of the broken dried films were separated by size with a sieve to remove particles less than 15 mesh size.
    • 11) The collected particles were placed into a vacuum oven set to 40 C for 24 hrs, to provide finished dry granules.

Claims
  • 1. A composition comprising: a cannabis composition comprising a collection of dry granules, wherein the collection of dry granules comprises:(i) a solvent extracted cannabinoid or cannabinoids;(ii) a surfactant;(iii) a carrier oil; and(iv) a sugar alcohol,wherein the cannabis composition comprises a dose of 0.1 to 10 mg of the cannabinoid or cannabinoids present in a consistent amount and having less than 0.2 mg of deviation across sample portions of the composition, andwherein the cannabis composition comprises less than 10 mass % water.
  • 2. The composition of claim 1, wherein the cannabis composition comprises less than about 2 grams of carbohydrate and less than about 2 grams of fat.
  • 3. The composition of claim 1, wherein the cannabis composition comprises a dose of 0.5 mg to 5 mg of the solvent extracted cannabinoid.
  • 4. The composition of claim 1, wherein the cannabis composition comprises cannabis oil that includes the solvent extracted cannabinoid.
  • 5. The composition of claim 1, wherein the cannabis composition is in the form of an homogenous dehydrated beverage.
  • 6. The composition of claim 1, wherein the cannabis composition comprises less than 4 grams of caloric material.
  • 7. The composition of claim 1, wherein the dry granules have a particle size greater than 15 mesh.
  • 8. The composition of claim 1, wherein the solvent extracted cannabinoid or cannabinoids are selected from the group consisting of tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), cannabitriol (CBT), cannabigerol (CBG), cannabichromene (CBC), cannabigerolic acid (CBGA), cannabidolic acid (CBDA), tetrahydrocannabivarin (THCV), cannabicyclol, cannabivarin, cannabielsoin, cannabicitran, cannabigerolic acid monomethylether, cannabigerol monomethylether, cannabigerovarinic acid, cannabigerovarin, cannabichromenic acid, cannabichromevarinic acid, cannabichromevarin, cannabidiol monomethylether, cannabidiol-C4, cannabidivarinic acid, cannabidiorcol, delta-9-tetrahydrocannabinolic acid A, delta-9-tetrahydrocannabinolic acid B, delta-9-tetrahydrocannabinolic acid-C4, delta-9-tetrahydrocannabivarinic acid, delta-9-tetrahydrocannabivarin, delta-9-tetrahydrocannabiorcolic acid, delta-9-tetrahydrocannabiorcol, delta-7-cis-isotetrahydrocannabivarin, delta-8-tetrahydrocannabiniolic acid, delta-8-tetrahydrocannabinol, cannabicyclolic acid, cannabicylovarin, cannabielsoic acid A, cannabielsoic acid B, cannabinolic acid, cannabinol methylether, cannabinol-C4, cannabinol-C2, cannabiorcol, 10-ethoxy-9-hydroxy-delta-6a-tetrahydrocannabinol, 8,9-dihydroxy-delta-6a-tetrahydrocannabinol, cannabitriolvarin, ethoxycannabitriolvarin, dehydrocannabifuran, cannabifuran, cannabichromanon, cannabicitran, 10-oxo-delta-6a-tetrahydrocannabinol, delta-9-cistetrahydrocannabinol, 3, 4, 5, 6-tetrahydro-7-hydroxy-alpha-alpha-2-trimethyl-9-npropyl-2, 6-methano-2H-1-benzoxocin-5-methanol-cannabiripsol, trihydroxy-delta-9-tetrahydrocannabinol, derivatives thereof, and combinations thereof.
  • 9. The composition of claim 1, wherein the solvent extracted cannabinoid or cannabinoids comprises at least one of cannabidiol (CBD) or tetrahydrocannabinol (THC).
  • 10. The composition of claim 1, wherein the solvent extracted cannabinoid is cannabidiol (CBD).
  • 11. The composition of claim 1, wherein the surfactant is an amphoteric surfactant.
  • 12. The composition of claim 1, wherein the surfactant comprises a glucoside or lecithin.
  • 13. The composition of claim 1, wherein the carrier oil comprises medium chain triglycerides.
  • 14. The composition of claim 1, wherein the carrier oil comprises coconut oil.
  • 15. The composition of claim 1, wherein the sugar alcohol is selected from the group consisting of sorbitol, maltitol, xylitol, and erythritol.
  • 16. The composition of claim 1, wherein the sugar alcohol is sorbitol.
  • 17. The composition of claim 1, wherein the cannabis composition further comprises a flavoring agent, a coloring agent, or both a flavoring agent and a coloring agent.
  • 18. The composition of claim 1, wherein the cannabis composition further comprises a gelling agent comprising a natural gum or a starch or gelatin.
  • 19. The composition of claim 18, wherein the gelling agent comprises a starch.
  • 20. The composition of claim 18, wherein the gelling agent comprises a natural gum.
  • 21. The composition of claim 18, wherein the gelling agent comprises gelatin.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/571,610, filed on Sep. 16, 2019, which issued as U.S. Pat. No. 11,980,204 on May 14, 2024, which is a continuation of U.S. patent application Ser. No. 15/084,954, filed on Mar. 30, 2016, now abandoned, which claims the benefit of priority to U.S. Provisional Application No. 62/163,316, filed on May 18, 2015, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (82)
Number Name Date Kind
3506457 Gidlow et al. Apr 1970 A
4830862 Braun et al. May 1989 A
5118511 Horn et al. Jun 1992 A
5284674 Fazio Feb 1994 A
5554400 Stipp Sep 1996 A
6287592 Dickinson Sep 2001 B1
6365176 Bell Apr 2002 B1
6440449 Hirschberg Aug 2002 B1
6482433 DeRoos Nov 2002 B1
6858245 DeConinck Feb 2005 B2
6887493 Shefer et al. May 2005 B2
7147882 Girsh Dec 2006 B2
8734885 Sweeney May 2014 B2
8808734 Winnicki Aug 2014 B2
8980941 Hospodor Mar 2015 B2
9474725 Reillo et al. Oct 2016 B1
9629886 Franklin et al. Apr 2017 B2
9839612 Reillo Dec 2017 B2
9937147 DeGeeter Apr 2018 B2
9972680 Reillo May 2018 B2
9974739 Reillo May 2018 B2
10016363 Bromley Jul 2018 B2
10028919 Kaufman Jul 2018 B2
10084044 Reillo Sep 2018 B2
10103225 Reillo Oct 2018 B2
10374036 Reillo Jan 2019 B2
10381440 Reillo Aug 2019 B2
10413845 Tegen et al. Sep 2019 B1
10414709 Tegen et al. Sep 2019 B1
10756180 Reillo Aug 2020 B2
20020127303 Chen et al. Sep 2002 A1
20020136752 Whittle et al. Sep 2002 A1
20020188024 Chilton et al. Dec 2002 A1
20040234579 Finke Nov 2004 A1
20050077497 Anderson Apr 2005 A1
20070104741 Murty et al. May 2007 A1
20070213298 Rongved et al. Sep 2007 A1
20080008781 Sweeney et al. Jan 2008 A1
20080064679 Martin et al. Mar 2008 A1
20080206325 Bouquerand et al. Aug 2008 A1
20080254153 Wang et al. Oct 2008 A1
20090095164 Celeste Apr 2009 A1
20090162524 Rivera et al. Jun 2009 A1
20090264475 Schwartz Oct 2009 A1
20100034888 Pellikaan et al. Feb 2010 A1
20110092583 Murty et al. Apr 2011 A1
20120043242 Hospodor Feb 2012 A1
20120095087 Hyatt Apr 2012 A1
20120231083 Carley et al. Sep 2012 A1
20130078356 Mackereth et al. Mar 2013 A1
20130089600 Winnicki Apr 2013 A1
20130164412 Amrani Jun 2013 A1
20130196022 Holma Aug 2013 A1
20130296415 Goskonda et al. Nov 2013 A1
20130309291 Stoll Nov 2013 A1
20130337113 Clark et al. Dec 2013 A1
20140100269 Goskonda et al. Apr 2014 A1
20140295049 Ragot et al. Oct 2014 A1
20140328997 Raskin et al. Nov 2014 A1
20140357708 Murty et al. Dec 2014 A1
20140370181 Young et al. Dec 2014 A1
20150045282 Elsohly et al. Feb 2015 A1
20150057341 Perry Feb 2015 A1
20150079235 Wright et al. Mar 2015 A1
20150110924 Bromley Apr 2015 A1
20150258040 Lynch et al. Sep 2015 A1
20150352044 Benson et al. Dec 2015 A1
20160051510 Allen et al. Feb 2016 A1
20160058866 Sekura et al. Mar 2016 A1
20160143972 Stebbins et al. May 2016 A1
20160324776 Glatzel Nov 2016 A1
20170049830 Raderman Feb 2017 A1
20170172977 Kleidon et al. Jun 2017 A1
20180007924 Goldstein et al. Jan 2018 A9
20180125980 Finley et al. May 2018 A1
20180360704 Riefler et al. Dec 2018 A1
20190015383 Woelfel et al. Jan 2019 A1
20190240148 Riefler et al. Aug 2019 A1
20190276420 Tegen et al. Sep 2019 A1
20200008441 Goldstein et al. Jan 2020 A1
20200071285 Tegen et al. Mar 2020 A1
20200113825 Victor et al. Apr 2020 A1
Foreign Referenced Citations (16)
Number Date Country
2952335 Jun 2017 CA
101904401 Dec 2010 CN
104619318 May 2015 CN
1437136 Jul 2004 EP
1999035917 Jul 1999 WO
2012130278 Oct 2012 WO
2013138906 Sep 2013 WO
2014186896 Nov 2014 WO
2015024055 Feb 2015 WO
2015191728 Dec 2015 WO
2016186735 Nov 2016 WO
WO 2017072762 May 2017 WO
2017180954 Oct 2017 WO
2017202424 Nov 2017 WO
2018011808 Jan 2018 WO
2018204326 Nov 2018 WO
Non-Patent Literature Citations (4)
Entry
Datbase WPI, Week 201381 Thomas Scientific. XP002787597, May 22, 2013, London, GB; AN 2013-R00947 & CN 103110582A (3 pages).
International Search Report for PCT/US2016/025044 dated Jun. 27, 2016 (2 pages).
Grembecka, Malgorzata, “Sugar alcohols—Their Role in the Modern World of Sweeteners: a Review,” Eur. Food Res. Technol., 214:1-14 (2015).
United Nations, Office on Drugs and Crime, World Drug Report 2009 Series, Why does cannabis potency matter?, Jun. 29, 2009, https://www.unodc.org/unodc/en/frontpage/2009/June/why-does-cannabis-potency-matter.html, retrieved online Dec. 7, 2021 (2009).
Related Publications (1)
Number Date Country
20230413845 A1 Dec 2023 US
Provisional Applications (1)
Number Date Country
62163316 May 2015 US
Continuations (2)
Number Date Country
Parent 16571610 Sep 2019 US
Child 18340572 US
Parent 15084954 Mar 2016 US
Child 16571610 US